Form 8-K - Current report:
SEC Accession No. 0001193125-25-134502
Filing Date
2025-06-04
Accepted
2025-06-04 08:33:10
Documents
12
Period of Report
2025-06-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d26124d8k.htm   iXBRL 8-K 24874
  Complete submission text file 0001193125-25-134502.txt   138386

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iobt-20250603.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE iobt-20250603_lab.xml EX-101.LAB 17910
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iobt-20250603_pre.xml EX-101.PRE 11238
14 EXTRACTED XBRL INSTANCE DOCUMENT d26124d8k_htm.xml XML 3616
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Filer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41008 | Film No.: 251021999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)